Clinical effectiveness of lopinavir in the management of Covid-19 infection and prevention.

COVID-19 also known as Coronavirus 2019, is currently declared by WHO as a new pandemic
disease caused by a single-stranded RNA zoonotic virus termed severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) (Lu et al. 2020). The complete viral genome analysis shows that the…

Design and testing of novel viral fusion inhibitors against SARS-CoV-2

This project has employed computational (in silico) methods to design a novel class of inhibitors against the SARS-CoV-2 virus (COVID-19). The project has employed state-of-the-art computer-aided drug design (CADD) methods to develop an initial library of putative small molecule inhibitors. Because…